메지온 유데나필, ADPKD 낭종·신장기능 동시 개선…“한·미 임상 2b상 직행” pharm.edaily.co.kr/news/read?newsId=05024966645545024&mediaCodeNo=257

Channel
팜이데일리 뉴스룸
@pharmedaily
On this record: Growth · Engagement · Posts · Citations · Cite this entry
356subscribers
+9 since we began measuring on 7 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
Register entry
| Telegram ID | -1002382838683 |
|---|---|
| Type | Channel |
| Username | @pharmedaily |
| Created | Between 1 September 2024 and 31 March 2025 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 8 August 2026 |
| Last confirmed live | 5 September 2026 |
| Measurements held | 6 |
| Confirmed unchanged | 1 time, most recently 5 September 2026 |
| On Telegram | t.me/pharmedaily |
Growth
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 5 Sept 2026, 23:59 | 356 | +1 |
| 29 Aug 2026, 04:07 | 355 | +5 |
| 22 Aug 2026, 15:55 | 350 | +2 |
| 16 Aug 2026, 06:13 | 348 | +1 |
| 8 Aug 2026, 06:49 | 347 | no change |
| 7 Aug 2026, 13:17 | 347 | first reading |
Engagement
20 posts held, back to 31 July 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 7 August 2026. An engagement rate over an empty window would be a number about nothing.
Recent posts
자큐보 인도 허가에 온코닉 급등…큐리언트·보로노이도 강세[바이오맥짚기] pharm.edaily.co.kr/news/read?newsId=04090166645545024&mediaCodeNo=257
[전문가 인사이트]민경준 뉴민병원장 “관절 치료, ‘보존’으로 패러다임 변해…카티라이프 주목” pharm.edaily.co.kr/news/read?newsId=04080326645545024&mediaCodeNo=257
“사람 모낭이 자랐다”…오르엔트바이오 OND-1, 미녹시딜보다 탈모 치료 효과 10배 강력 pharm.edaily.co.kr/news/read?newsId=03207846645544368&mediaCodeNo=257
디앤디파마텍, 해명에도 18% 하락…K비만치료제 ‘기대감 흔들’[바이오맥짚기] pharm.edaily.co.kr/news/read?newsId=03001206645544696&mediaCodeNo=257
韓 규제 정비·美 관세 예외…삼성바이오로직스 직접 수혜군 주목 pharm.edaily.co.kr/news/read?newsId=02889686645544696&mediaCodeNo=257
길영준 휴이노 대표 “메모큐 확산세 빨라...내년 흑자전환 기대” pharm.edaily.co.kr/news/read?newsId=02669926645544696&mediaCodeNo=257
20년 인보사, 10월이 마지막 승부…코오롱티슈진, 또 실패해도 끌고 갈까? pharm.edaily.co.kr/news/read?newsId=02132006645544040&mediaCodeNo=257
[단독]병원 잡으려 반값 경쟁…AI 환자 모니터링 시장 ‘치킨게임’ 우려 pharm.edaily.co.kr/news/read?newsId=01715446645543712&mediaCodeNo=257
리포트 한 장에 20% 급등...큐리언트·앱클론 날고, 엘앤씨바이오는 유증 재평가[바이오맥짚기] pharm.edaily.co.kr/news/read?newsId=02122166645544368&mediaCodeNo=257
구글·애플·MS 다 잡은 닷 김주윤 대표 "수술로봇 사업 확장...주요 기업과 협업 중" pharm.edaily.co.kr/news/read?newsId=02715846645544040&mediaCodeNo=257
딥노이드·펩트론 上…엘앤씨바이오는 유상증자에 약세[바이오맥짚기] pharm.edaily.co.kr/news/read?newsId=02505926645544040&mediaCodeNo=257
Showing the 12 most recent of 20 posts we hold for @pharmedaily. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Forward network
Republished by
Channels on the register that have forwarded this channel's posts into their own feed.
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
Cite this entry
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 5 September 2026 — this entry's latest reading, not the date you are reading this.
“팜이데일리 뉴스룸” (@pharmedaily), 356 subscribers as measured 5 September 2026. Telegram Register, tgregister.com/channel/pharmedaily.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.